Rotavirus Gastroenteritis Clinical Trial
Official title:
Phase I/II, Randomized, Double-blind, Placebo-controlled, Dosage Selection (10e5.5 or 10e6.25 FFU of Each Constituent Serotype Per 0.5 mL) Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-dose Series of Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] Administered to Healthy Indian Infants
A double blind placebo controlled Phase I/II study to evaluate the safety and immunogenicity of the Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV]in Indian infants. The study would be carried out in 90 healthy infants. Three doses of the rotavirus vaccine or placebo would be administered orally to each infant at 6-8, 10-12 and 14-16 weeks of age. The rotavirus vaccine would be administered at one of the two planned virus concentrations (10e5.5 or 10e6.25 FFU of each constituent serotype per 0.5 ml). Each administration of the vaccine/placebo would be preceded by oral administration of 2.0 mL of antacid.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01575197 -
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
|
Phase 4 | |
| Completed |
NCT01202201 -
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
|
N/A | |
| Completed |
NCT00953056 -
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
|
Phase 1 | |
| Completed |
NCT00737503 -
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
|
Phase 4 | |
| Completed |
NCT04185545 -
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
|
Phase 3 | |
| Completed |
NCT03474055 -
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
|
Phase 2/Phase 3 | |
| Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
| Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
| Completed |
NCT02584816 -
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization
|
Phase 3 | |
| Completed |
NCT02062385 -
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
|
Phase 3 | |
| Completed |
NCT02133690 -
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
|
Phase 3 | |
| Completed |
NCT01177657 -
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
|
N/A | |
| Completed |
NCT00740935 -
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
|
Phase 4 | |
| Completed |
NCT01265355 -
Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement
|
Phase 2/Phase 3 | |
| Completed |
NCT00169455 -
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
|
Phase 3 | |
| Completed |
NCT04819412 -
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
|
Phase 3 | |
| Completed |
NCT02728869 -
Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05958771 -
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
|
Phase 3 | |
| Completed |
NCT01026779 -
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
|
||
| Completed |
NCT01508533 -
Epidemiology of Rotavirus Infection in North India Community
|
N/A |